We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$2.93B
AUM Growth
-$232M
Cap. Flow
-$337M
Cap. Flow %
-11.5%
Top 10 Hldgs %
37.72%
Holding
51
New
–
Increased
2
Reduced
36
Closed
2

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$37.8M
2
ABT icon
Abbott
ABT
+$34.5M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$97.2M
2
DD icon
DuPont de Nemours
DD
+$18.7M
3
SLB icon
SLB Ltd
SLB
+$17.3M
4
PPL
PPL Corp
PPL
+$14.7M
5
DIS icon
Walt Disney
DIS
+$13.9M

Sector Composition

Rank Sector Weight
1 Healthcare 21.2%
2 Industrials 14.08%
3 Communication Services 12.63%
4 Energy 12.32%
5 Utilities 11.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBM icon
51
IBM
IBM
$222B
– –
-528,068
Closed -$97.2M
1 2
3

Similar funds

LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
BC
Blackstart Capital New York $151M AUM 14.01% 1-Year Est. Return
JT
Jump Trading Chicago, Illinois $150M AUM 17.61% 1-Year Est. Return
SCM
Stellar Capital Management Phoenix, Arizona $147M AUM 5.91% 1-Year Est. Return
HF
Hellman & Friedman San Francisco, California $169M AUM
SMFS
Squar Milner Financial Services Irvine, California $176M AUM 10.56% 1-Year Est. Return
CCM
Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return
CCM
Castine Capital Management Boston, Massachusetts $129M AUM 23.45% 1-Year Est. Return

Stralem & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Stralem & Co held 51 positions worth $2.93B, down 7.3% from $3.17B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Stralem & Co withdrew a net $337M in Q2 2014, closing 2 positions and reducing 36 holdings. Its most notable exit was IBM, an estimated $97.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Stralem & Co added an estimated $37.8M to Amgen.

  • Stralem & Co added most to Amgen in Q2 2014, an estimated $37.8M increase.
  • Stralem & Co's biggest Q2 2014 reduction was DuPont de Nemours, cutting an estimated $18.7M.
  • Stralem & Co fully exited IBM in Q2 2014, selling an estimated $97.2M.
  • Stralem & Co's ten largest holdings make up 38% of its $2.93B portfolio in Q2 2014.
  • Stralem & Co opened 0 new positions and closed 2 in Q2 2014.
  • Stralem & Co's portfolio value fell 7.3% quarter-over-quarter to $2.93B.

Based on Stralem & Co's 13F filing for Q2 2014, filed 16 Jul 2014.